Vaccine Clinical Trials Excellence in Thailand

The pharmaceutical industry is inherently complex, with growing digital sophistication necessitating more personalized and patient-centric trials. Navitas Life Sciences, a full-service technology-led CRO, transcends the complexities of the CRO research landscape. As one of the top clinical research organizations globally, with over 600+ clinical trials conducted across 20+ therapeutic areas, it distinguishes itself as a leading CRO clinical research organization.

Through its comprehensive services as a CRO contract research organization, which includes regulatory and pharmacovigilance support, Navitas Life Sciences pilots the intricacies of clinical research with precision, during drug development and beyond, setting the standard for the best and largest clinical research organizations worldwide.

Leveraging our Capabilities in Thailand

Navitas Life Sciences stands as one among premier cro companies in usa, headquartered in New Jersey, with a robust global presence. Renowned as one of the best clinical research organizations, Navitas Life Sciences operates at the forefront of innovative research, offering comprehensive solutions to small to large pharmaceutical, biotechnology, and medical device companies. With a track record of excellence and a commitment to delivering high-quality outcomes, Navitas Life Sciences has earned its place among the largest clinical research organizations globally.

Experience in Thailand:

Navitas Thailand boasts comprehensive facilities and a seasoned team capable of overseeing all aspects of clinical research. With a proficient ensemble comprising Clinical Research Associates, Clinical Project Managers, and Clinical Trial Assistants, we offer end-to-end services ranging from feasibility assessments to project management, ensuring seamless execution at every stage.

Clinical Trials Landscape:

Within our Thailand premises, Navitas conducts an array of clinical trials spanning diverse therapeutic areas. From oncology and cardiovascular diseases to chronic kidney disease, thalassemia, and crucially, influenza vaccine,DTP vaccine, covid-19 vaccine and baby nutrition studies, our portfolio reflects a commitment to addressing pressing healthcare needs.

In a candid conversation with Jurairat Buasuwan, General Manager and Head of Thailand Operations at Navitas Life Sciences, we explore the intricacies of clinical trials in Thailand and how NLS is at the forefront of this dynamic field.

Jurairat Buasuwan

General Manager and Head of Thailand Operations,

Navitas Life Sciences

Please provide an overview of the facilities available for clinical trials research in Thailand.

At Navitas Thailand, we offer comprehensive end-to-end services for all clinical research requirements. Our expert team comprises Clinical Research Associates, Clinical Project Managers, and Clinical Trial Assistants, ensuring seamless execution from feasibility assessments to site selection, start-up, and project management.

What types of clinical trials are typically conducted in our Thailand premises, and which therapeutic areas are most prevalent?

NLS Thailand conducts a diverse range of clinical trials, including oncology, cardiovascular diseases (CVD), chronic kidney disease (CKD), thalassemia, and studies focusing on baby nutrition. Vaccine, including influenza vaccine clinical trial, Diphtheria-Tetanus-Pertussis vaccine, and covid vaccine studies, and baby nutrition trials emerge as the most prevalent therapeutic areas.

How does Thailand's regulatory environment support clinical research activities?

Thailand's regulatory authorities prioritize subject safety and facilitate efficient approval processes. Concurrent reviews by regulatory bodies and ethics committees expedite approvals, fostering a conducive environment for clinical research activities.

Are there any specific challenges or advantages to conducting clinical trials in Thailand compared to other countries in the region?

Conducting clinical trials in Thailand offers several advantages. The excellence and diversity of subject populations, abundant medical expertise, advanced healthcare facilities adhering to international standards, cost-effectiveness, and supportive government policies, including funding initiatives, collectively enhance the research landscape in Thailand.

What are the quality standards maintained by research facilities in Thailand, including Good Clinical Practice (GCP) adherence and accreditation?

Navitas Thailand upholds stringent quality standards, including adherence to Good Clinical Practice (GCP) guidelines. Our commitment to quality is demonstrated through internal system audits, sponsor audits, and inspections by the Thai FDA.

What are some of the notable studies conducted in Thailand?

Notable studies conducted in Thailand include vaccine trials, particularly those addressing the Covid vaccine, contributing significantly to global public health initiatives and advancing medical research in the region.

We carried out a key COVID-19 vaccine study, with first patient in on the first day, and recruitment of patients ahead of time! Navitas Life Sciences is excellent at clinical trial site management with the site for the study activated in one day!

We received good appreciation from the sponsors, with award of multiple new studies. The study passed Thai FDA inspection without critical or major findings.

Navitas Life Sciences stands as a beacon of excellence in Thailand's clinical research landscape, leveraging expertise, innovation, and unwavering commitment to advancing healthcare solutions. As a top-tier Clinical Research Organization (CRO), we remain steadfast in our mission to drive groundbreaking research and propel medical advancements that transform lives worldwide.

To learn more about our services and solutions, reach out to us at This email address is being protected from spambots. You need JavaScript enabled to view it.